AzTrials
AzTrials

Oxygen Supply AbsentNCT06661525

Monitoring Free Tissue Transfer Hemodynamics Using NIRS

A study testing Free Flap NIRS in people with Oxygen Supply Absent, run by University of British Columbia at 2 sites in Canada.

Enrolling by invitation

Enrolling by invitation. The study team selects and invites participants, usually from an existing group of patients.

Sites and contacts
Official record
Search all trials

Trial summary

Free tissue transfer (FTT) is a surgical procedure for repairing cancer resection wounds. Free tissue transfer usually involves taking skin from one area of the body (e.g. leg) and transplanting it to the surgically created wound (e.g. neck wound). Due to problems with anastomosis, the transplanted skin can die. Read more about this study

Who is it for?
Ages 18 to 60 years
Conditions the study is for
Oxygen Supply Absent
What is being tested?
Free Flap NIRS
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
2 sitesCanada
Study dates
20 Apr 2025to 1 Sep 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • 60 patients undergoing a variety of free tissue transfer for head and neck cancer. The result of the reconstruction should be easily visible to the clinicians.
  • Age of 18 years old or older

Who cannot join

  • Serious medical condition or other disease which occurs at the same time
  • Metastatic disease
  • Pregnant or nursing

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Canada2 sites
  • Surrey Memorial Hospital

    Surrey, British Columbia, V3V 1Z2

  • Vancouver General Hospital

    Vancouver, British Columbia, V5Z 1M9

Other trials in Canada

About this study

Official title: Advanced Optical Monitoring of Free Tissue Transfer Hemodynamics

Free tissue transfer (FTT) is a surgical procedure for repairing cancer resection wounds. Free tissue transfer usually involves taking skin from one area of the body (e.g. leg) and transplanting it to the surgically created wound (e.g. neck wound). Due to problems with anastomosis, the transplanted skin can die. If the poor blood supply can be detected early, transplanted skin can be saved by taking patients back to the operating room. The investigators propose to improve the design and test a novel, non-invasive monitoring system specifically for head and neck surgeries for early detection of poor blood supply to the transplanted tissue after FTT surgery.

Read the detailed description

PURPOSE: To improve the design and evaluation of a novel spatially resolved near-infrared spectroscopy (NIRS) system customized for continuous postoperative free tissue transfer (FTT) monitoring and to make this system commercially available.

HYPOTHESIS: The novel NIRS device is capable of monitoring FTT reconstruction continuously for 72 hours after surgery with minimal interference to patient care, minimal discomfort to the patient, and minimal interference with clinical assessment.

JUSTIFICATION FOR THE STUDY: FTT consists of transplanting skin, muscle or bone along with its feeding blood vessels from one body site to reconstruct a defect created by removing cancerous tumours or traumatic injury at a separate site. The key to the survival of the transplanted tissue is the meticulously created microvascular anastomosis between the blood vessels of the transplanted tissue and the blood vessels of the recipient site. Microsurgical techniques have been refined over time to maintain the patency of the anastomosed blood vessels. Nevertheless, the current FTT failure rate is between 1 and 10%.

When FTT failure occurs, it is a devastating experience for the patient and the surgical team. The patient has to be urgently brought to the operating room for an attempted salvage of the microvascular anastomosis. In the event of unsuccessful salvage, the patient has to undergo multiple surgeries that compound the associated morbidity, prolong hospital stay, and increase health care costs. Early detection of vascular compromise is essential for increasing the odds of successful salvage. Thus, the methods used to monitor the FTT vascular status are critical and have received much attention in the literature. Clinical examination remains the gold standard and the most popular method of monitoring FTT viability. The two downsides of clinical examinations are the requirement for personnel trained and experienced in FTT monitoring and the inability to provide reliable continuous monitoring. Therefore recognition of FTT compromise is often delayed significantly compromising successful surgical salvage attempts.

Recently, NIRS has been recognized as the technology with the most potential to address the problems seen with FTT clinical monitoring. NIRS is a non-invasive technique that passes near-infrared light (600-1000 nm) through the tissues at a depth of 10 to 20 mm. Calculating the amount of absorbed light allows real-time measurements of oxygenated, deoxygenated, and total hemoglobin concentrations. Therefore, an abnormality of tissue perfusion and oxygenation can then be detected instantaneously and confirmed clinically. Reducing the time from detection of vascular compromise to the attempted FTT rescue in the operating room decreases the ischemia time and increases the FTT salvage rate.

A recent meta-analysis concluded that NIRS is "a reliable monitoring technique that is non-invasive, objective, and easy to use". However, there are currently no NIRS systems available that can monitor FTT used in head and neck surgery. This is largely due to the difficulty in creating NIRS sensors that are small enough to be used in the head and neck region. Developing and evaluating a novel, customized NIRS system with a miniaturized sensor suitable for a variety of FTT options is needed, presenting an attractive clinical opportunity.

The proposed study's principal investigator (D.W.A.) is the pioneer of head and neck FTT in British Columbia, with FTT experience spanning over 35 years. He will use his expertise to consult with Dr. Shadgan, a clinical biophotonics research scientist, to provide clinical and technical specifications required for the construction of the NIRS prototype. Currently, they successfully built and tested the miniaturized NIRS sensor on 3 patients, and they were able to obtain promising results. To establish our method and refine the design of the sensor to be compatible with a wide variety of FTT surgeries, The investigators plan to conduct this pilot study.

OBJECTIVES

  1. Develop a novel NIRS system with miniaturized sensors suitable for various FTT reconstruction options.
  2. Conduct a pilot study on up to 60 patients to determine perfusion thresholds indicative of vascular compromise for a variety of FTT reconstructive options, and to improve the design and application of sensors to the variety of FTT.

RESEARCH DESIGN

The NIRS prototype will be tested intra- and post-operatively on a single patient undergoing FTT reconstruction. Intra-operative NIRS measurements simulating FTT compromise will be collected during a single FTT operation.

Post-operatively the NIRS probe will be placed and fixed over the FTT for 72 hours and its measurements will be recorded. In addition, experienced nurses not involved in the proposed study will monitor the FTT vascular status with the conventional clinical methods currently employed at VGH and Surrey Memorial Hospital. The clinical assessment will be documented in the standardized table and correlated to the NIRS recordings. Finally, at the end of the 72-hours, both the patient and the clinicians will complete questionnaires to evaluate their experience with the NIRS system.

STATISTICAL ANALYSIS

The collected intra-operative and post-operative NIRS measurements will be used to establish a threshold for low perfusion alarm on the NIRS monitor for different types of tissues.

The data that will be collected through patients' and doctors' questionnaires will go through descriptive statistical analysis.

Being tested
Free Flap NIRS
Keywords
NIRS Sensor, Tissue Oxygenation, Free Tissue Transfer (FTT)
Medical subject headings
Hypoxia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Free Flap NIRSDevice

    Monitoring of tissue oxygenation after Free Tissue Transfer (FTT) surgeries.

Study groups in NCT06661525
Study groupRoleWhat they receive
ParticipantsExperimentalData collection from Participants and evaluate their feedback by filling a questioner
Receives: Device: Free Flap NIRS
Care providersActive comparatorCare providers will provide their feedback via questioner
Receives: Device: Free Flap NIRS

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Establish a baseline Total Oxygenation Index (TOI) to measure NIRS on FTT cases

    The total oxygenation index (TOI) measurements will be used to establish a TOI baseline for Free Tissue Transfer (FTT) and to calibrate and tune the FTT-system

    Measured: Up to 36 months

  2. Enhance the design and accuracy of the FTT- NIRS sensor based on patient and clinicians feedback

    The data collected will be used to enhance the design and accuracy of the next generation of NIRS sensors based on the feedback provided by the patient and clinician

    Measured: 24 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Oct 2024
  2. Study start20 Apr 2025
  3. Primary completion29 Dec 2026 (estimated)
  4. Study completion1 Sep 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Care provider
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06661525
Sponsor's protocol ID
H22-03706
Status last verified
Apr 2026
First submitted
2 May 2024
Last updated
1 May 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Free Flap NIRS in people with Oxygen Supply Absent, run by University of British Columbia at 2 sites in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: enrolling by invitation, as of the sponsor's last update on 1 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Establish a baseline Total Oxygenation Index (TOI) to measure NIRS on FTT cases (time frame: Up to 36 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in